ACADIA Pharmaceuticals' GAAP loss for the 3 months of 2022 was $113.056 million, up 70.1% from $66.448 million in the previous year. Revenue increased 8.4% to $115.468 million from $106.554 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept